欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4087/002
药品名称NuTRIflex Lipid peri novo Emulsion zur Infusion
活性成分
    • alanine 3.88 g
    • arginine 2.16 g
    • aspartic acid 1.2 g
    • calcium chloride 0.47 g
    • glucose 70.4 g
    • glutamic acid 2.8 g
    • glycine 1.32 g
    • HISTIDINE HYDROCHLORIDE 1.62 g
    • isoleucine 2.26 g
    • leucine 3.01 g
    • lysine 2.73 g
    • MAGNESIUM ACETATE 0.69 g
    • methionine 1.88 g
    • phenylalanine 3.37 g
    • potassium 2.75 g
    • proline 2.72 g
    • serine 2.4 g
    • sodium chloride 0.4 g
    • sodium dihydrogen phosphate 1.87 g
    • threonine 1.74 g
    • tryptophan 0.54 g
    • valine 2.08 g
    • zinc acetate, basic 5.28 g
剂型Emulsion for infusion
上市许可持有人B. Braun Melsungen AG Carl-Braun-Strasse 1 34212 Melsungen Germany
参考成员国 - 产品名称Germany (DE)
Nutriflex Lipid 32/64 peri (alt:Lipoflex peri Emulsion zur Infusion)
互认成员国 - 产品名称
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Denmark (DK)
    • Belgium (BE)
    • Romania (RO)
      NuTRIflex Lipid peri novo emulsie perfuzabilă
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
许可日期2016/05/19
最近更新日期2024/04/11
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase